Medpace CEO August J. Troendle Sells $6.75M in Common Stock

Insider Transaction Overview

On September 17, 2026, August J. Troendle, President, CEO, Director, and 10% Owner of Medpace Holdings, Inc. (NASDAQ: MEDP), executed an open-market sale of 10,880 shares of common stock at a weighted average price of $620.40, generating gross proceeds of approximately $6.75 million.

Transaction Breakdown

• Security: Common Stock
• Transaction Code: S (Open market or private sale)
• Execution Details: The shares were sold in multiple trades ranging from $620.00 to $622.21 pursuant to a limit order placed during an open trading window.
• Post-Transaction Holdings:
  • Direct Ownership: 504,273 shares remaining.
  • Indirect Ownership: 4,733,019 shares held via Medpace Investors, LLC.

Significance & Market Context

While a $6.75M insider sale is substantial in nominal dollar terms, it represents approximately 0.2% of Troendle's total beneficial holdings (which exceed 5.23 million shares valued at over $3.2 billion). As founder and CEO, Troendle maintains an overwhelming equity stake and controlling interest in the company. Consequently, this sale is categorized as Medium significance, likely serving routine portfolio rebalancing or liquidity purposes rather than signaling a shift in operational sentiment.